Back to Search
Start Over
Genetic alterations in myeloproliferative and myelodysplastic/myeloproliferative neoplasms – a practical guide to WHO-HAEM5.
- Source :
-
Medizinische Genetik . Apr2024, Vol. 36 Issue 1, p31-38. 8p. - Publication Year :
- 2024
-
Abstract
- Within the World Health Organization (WHO) classification of haematopoietic neoplasms, particularly its fifth version from 2022 (WHO-HAEM5), myeloid neoplasms are not only grouped into myeloproliferative (MPN) and myelodysplastic neoplasms (MDS). There is also a group of haematological disorders that share features of both categories termed myelodysplastic /myeloproliferative neoplasms (MDS/MPN). In this article, we aim to provide a comprehensive and practical guide to WHO-HAEM5 highlighting the genetic alterations that underlie MPN and MDS/MPN. This guide provides an overview of the overlapping commonalities among these entities, as well as their unique characteristics. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 09365931
- Volume :
- 36
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Medizinische Genetik
- Publication Type :
- Academic Journal
- Accession number :
- 175872731
- Full Text :
- https://doi.org/10.1515/medgen-2024-2003